UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P.021 Nonclinical studies of abuse potential with dual orexin-receptor antagonists: concordance with real-world use

Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S20-S20

2024

Volltextzugriff (PDF)

Pharmacotherapy for Nicotine Dependence

CA: a cancer journal for clinicians, 2005-09, Vol.55 (5), p.281-299

2005

Volltextzugriff (PDF)

The landscape of genomic alterations across childhood cancers

Nature (London), 2018-03, Vol.555 (7696), p.321-327

2018

Volltextzugriff (PDF)

Correlates of health‐related quality of life in children with drug resistant epilepsy

Epilepsia (Copenhagen), 2016-08, Vol.57 (8), p.1256-1264

2016

Volltextzugriff (PDF)

Early Neurologic Recovery, Practice Pattern Variation, and the Risk of Endotracheal Intubation Following Established Status Epilepticus

Neurology, 2021-05, Vol.96 (19), p.e2372

2021

Volltextzugriff (PDF)

Novel formulations and mechanisms of action for pain medications: new challenges to human abuse liability assessment and drug scheduling

The journal of pain, 2012-04, Vol.13 (4), p.S26-S26

2012

Volltextzugriff (PDF)

Abuse potential assessment of novel opioid analgesic NKTR-181: Implications for labeling and scheduling

Drug and alcohol dependence, 2014-07, Vol.140, p.e239-e239

2014

Volltextzugriff (PDF)

Recurrent MET fusion genes represent a drug target in pediatric glioblastoma

Nature medicine, 2016-11, Vol.22 (11), p.1314-1320

2016

Volltextzugriff (PDF)

Ketogenic Diet in Epileptic Encephalopathies

Epilepsy research and treatment, 2013-01, Vol.2013 (2013), p.1-5

2013

Volltextzugriff (PDF)

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months

Epilepsia (Copenhagen), 2013-01, Vol.54 (1), p.141-155

2013

Volltextzugriff (PDF)

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

The New England journal of medicine, 2010-03, Vol.362 (9), p.790-799

2010

Volltextzugriff (PDF)

Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes

Nicotine & tobacco research, 2001-05, Vol.3 (2), p.111-118

2001

Volltextzugriff (PDF)

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

Neurology, 2011-10, Vol.77 (15), p.1473-1481

2011

Volltextzugriff (PDF)

Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology

Neurology, 2011-01, Vol.76 (1), p.94-99

2011

Volltextzugriff (PDF)

Publisher Correction: Butler enables rapid cloud-based analysis of thousands of human genomes

Nature biotechnology, 2023-04, Vol.41 (4), p.578-578

2023

Volltextzugriff (PDF)

Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: Comparison between gas chromatography/mass spectrometry and immunoassay test strips

Nicotine & tobacco research, 2004-08, Vol.6 (4), p.615-620

2004

Volltextzugriff (PDF)

Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior

Nicotine & tobacco research, 2000-02, Vol.2 (1), p.39-43

2000

Volltextzugriff (PDF)

Acute effects of Advance: a potential reduced exposure product for smokers

Tobacco control, 2002-12, Vol.11 (4), p.376

2002

Volltextzugriff (PDF)

P.052 Trazodone for treating insomnia: abuse and safety risks

Canadian journal of neurological sciences, 2023-06, Vol.50 (s2), p.S72-S72

2023

Volltextzugriff (PDF)

Author Correction: The landscape of genomic alterations across childhood cancers

Nature (London), 2018-07, Vol.559 (7714), p.E10-E10

2018

Volltextzugriff (PDF)

Long-term safety and efficacy of clobazam for Lennox–Gastaut syndrome: Interim results of an open-label extension study

Epilepsy & behavior, 2012-12, Vol.25 (4), p.687-694

2012

Volltextzugriff (PDF)

Behavioral economic demand metrics for abuse deterrent and abuse potential quantification

Drug and alcohol dependence, 2019-05, Vol.198, p.13-20

2019

Volltextzugriff (PDF)

Acute effects of AdvanceTM: a potential reduced exposure product for smokers

Tobacco control, 2002-12, Vol.11 (4), p.376-378

2002

Volltextzugriff (PDF)

Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone

Pain medicine (Malden, Mass.), 2018-02, Vol.19 (2), p.307-318

2018

Volltextzugriff (PDF)

Rapid absorption of nicotine from new nicotine gum formulations

Pharmacology, biochemistry and behavior, 2009, Vol.91 (3), p.380-384

2009

Volltextzugriff (PDF)

1 – 25 von 341

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(313)
Mit Volltextzugriff
(251)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neurology
(32)
Epilepsia
(25)
Epilepsy & Behavior
(21)
Pediatric Neurology
(19)
Epilepsy Currents
(16)
Drug And Alcohol Dependence
(10)
Mayo Clinic Proceedings
(9)
Epiliepsy Currents/epilepsy Currents
(8)
Neuro-Oncology
(7)
Canadian Journal Of Neurological Sciences
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

P.021 Nonclinical studies of abuse potential with dual orexin-receptor antagonists: concordance with real-world use

Pharmacotherapy for Nicotine Dependence

The landscape of genomic alterations across childhood cancers

Correlates of health‐related quality of life in children with drug resistant epilepsy

Early Neurologic Recovery, Practice Pattern Variation, and the Risk of Endotracheal Intubation Following Established Status Epilepticus

Novel formulations and mechanisms of action for pain medications: new challenges to human abuse liability assessment and drug scheduling

Abuse potential assessment of novel opioid analgesic NKTR-181: Implications for labeling and scheduling

Recurrent MET fusion genes represent a drug target in pediatric glioblastoma

Ketogenic Diet in Epileptic Encephalopathies

Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: Initial monotherapy outcomes at 12 months

Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

Withdrawal-suppressing effects of a novel smoking system: comparison with own brand, not own brand, and de-nicotinized cigarettes

Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome

Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology

Publisher Correction: Butler enables rapid cloud-based analysis of thousands of human genomes

Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: Comparison between gas chromatography/mass spectrometry and immunoassay test strips

Preliminary evaluation of a novel smoking system: effects on subjective and physiological measures and on smoking behavior

Acute effects of Advance: a potential reduced exposure product for smokers

P.052 Trazodone for treating insomnia: abuse and safety risks

Author Correction: The landscape of genomic alterations across childhood cancers

Long-term safety and efficacy of clobazam for Lennox–Gastaut syndrome: Interim results of an open-label extension study

Behavioral economic demand metrics for abuse deterrent and abuse potential quantification

Acute effects of AdvanceTM: a potential reduced exposure product for smokers

Human Abuse Potential of the New Opioid Analgesic Molecule NKTR-181 Compared with Oxycodone

Rapid absorption of nicotine from new nicotine gum formulations

Suchergebnisse filtern